Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Romiplostim (Nplate) Peptide
Thrombopoietin-receptor peptibody for immune thrombocytopenia.
What is Romiplostim (Nplate)?
Romiplostim (Nplate) is a tpo mimetic · hematology peptide studied for chronic immune thrombocytopenia (itp) and pediatric itp. Below is an educational overview of Romiplostim (Nplate) peptide benefits, mechanism, common research protocols, dosage references, and known side effects.
Plain-Language Label Highlights
Brand names: Nplate
Chronic immune thrombocytopenia (ITP) in adults and children ≥1 year; hematopoietic syndrome of acute radiation.
A weekly injection that signals the bone marrow to make more platelets in people whose immune system destroys them.
- •Headache
- •Joint pain
- •Dizziness
- •Fatigue
- •Upper respiratory infection
- •Worsened thrombocytopenia after stopping
- •Thrombosis (clotting) when platelets rise too high
- •Bone marrow reticulin fiber deposition
- •Progression of MDS to AML (in MDS patients — off-label)
- •Myelodysplastic syndromes (not approved for MDS)
- •Severe hepatic impairment (caution)
- •Active thrombosis
Educational summary of the FDA prescribing information. Not a substitute for the full label or medical advice. Always discuss with a licensed prescriber.
Romiplostim (Nplate) Mechanism of Action
Peptibody (Fc-peptide fusion) containing TPO receptor-binding peptide domains that activate c-Mpl on megakaryocytes, stimulating platelet production without competing with endogenous TPO.
Romiplostim (Nplate) Research Areas & Benefits
Romiplostim (Nplate) Dosage & Common Research Protocols
Start 1 mcg/kg SC weekly; titrate to platelet count 50–200 × 10⁹/L (max 10 mcg/kg).
Protocols summarized for educational reference from published research. Not dosing guidance.
Romiplostim (Nplate) Studies & Cited Research
Romiplostim in chronic ITP
Sustained platelet responses vs placebo in splenectomized and non-splenectomized adults.
Why we trust this source: Published in a peer-reviewed scientific journal with editorial and reviewer oversight.
Citations are linked to PubMed, Google Scholar, and Crossref searches so you can verify the source independently. All references are reviewed during our editorial passes (last reviewed June 1, 2026).
Romiplostim (Nplate) Side Effects & Safety Considerations
- •FDA-approved.
- •Reticulin fiber deposition in bone marrow; thrombosis risk with over-correction.
Explore more peptides
Educational Information Only — Not Medical Advice
All content on this page is for educational and informational purposes only. It is not medical advice, diagnosis, or treatment. We make no claims that any peptide can diagnose, treat, cure, or prevent any disease. Peptides discussed are not FDA-approved for the indications listed unless explicitly stated otherwise.
Always consult a licensed healthcare provider before beginning any wellness protocol. Statements have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability, eligibility, and pricing may vary.
Ask the Library
Ask anything about peptides — answers come from our curated reference library with citations.